Results 51 to 60 of about 40,455 (302)

Commissural Misalignment Following Valve‐in‐Valve Transcatheter Aortic Valve Implantation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Data on commissural misalignment (CMA) during valve‐in‐valve transcatheter aortic valve implantation (ViV‐TAVI) for valve failure after surgical aortic valve replacement (SAVR) is scarce. Aims To study the impact of CMA on clinical and hemodynamic outcomes following ViV‐TAVI for failed SAVR.
Matthias Raschpichler, Johannes Rotta Detto Loria, Vivek Patel, Thilo Noack, Karoline Nüsser, Oliver Dumpies, Dhairya Patel, Takashi Nagasaka, Prateek Madaan, Aakriti Gupta, Holger Thiele, Michael A. Borger, Raj Makkar, Mohamed Abdel‐Wahab   +13 more
wiley   +1 more source

Reparo endovascular de válvula mitral con MitraClip®

Revista Colombiana de Cardiología, 2019
Resumen: La insuficiencia mitral severa es una entidad de alta prevalencia cuyo tratamiento de elección es quirúrgico. Sin embargo, la mayoría de veces una gran población no es intervenida por el alto riesgo quirúrgico.
Luis Miguel Benítez, Carlos Alberto Náder, Antonio José Lores, Ángela María Rodríguez, Jairo Cadena, Ángela María Cucalón, Mauricio Zúñiga, Camilo Arana, Antonio Enrique Dáger, Jaime Andrés Fonseca   +9 more
doaj   +1 more source

Mitral valve perforation from aortic insufficiency

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2013
A 60-year-old man with a history of endocarditis presented with congestive heart failure New York Heart Association class III symptoms. He did not have any signs or symptoms of microembolic phenomenon and the blood cultures were negative. A transesophageal echocardiogram showed an eccentric jet of mitral regurgitation (MR) from a perforation in the ...
Vikas, Singh, Claudia A, Martinez, William W, O'Neill   +2 more
openaire   +2 more sources

End stage cardiomyopathy and secondary mitral insufficiency: surgical alternative with prostesis implant and left ventricular remodelling [PDF]

, 2006
OBJECTIVE: To present a new surgical approach that consists of the implantation of a mitral prosthesis smaller than the annulus with traction of the papillary muscles to reduce the sphericalness of the left ventricle.
Branco, João Nelson Rodrigues, Breda, João Roberto, Buffolo, Enio, Catani, Roberto, Fonseca, José Honório de Almeida Palma da, Teles, Carlos Alberto   +5 more
core   +3 more sources

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Incidence and risk factors for pacemaker implantation following aortic valve replacement [PDF]

, 2010
Our aim was to identify the predictive factors for permanent pacemaker (PM) implantation in patients undergoing isolated aortic valve replacement (AVR).
Achim Häusler, Bateman, Boughaleb, Brodell, Burkhardt Seifert, Chung, Denis Berdajs, Glikson, Gordon, Jens Berli, Jensen, Keefe, Kim, Lewis, Limongelli, Lipton, Maximilian Emmert, Michele Genoni, Omer Dzemali, Thomas, Thomas, Ulrich P. Schurr, Warshawsky   +22 more
core   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Studies on an antifibrinolytic agent trans-AMCHA [PDF]

, 1968
Lysis of fibrin was first recognized by MORGAGNI in 1769, observing a liquid blood in a patient of acute death, and the phenomenon was named as fibrinolysis by DASTRE in 1893.
Fujiyama, Noboru, Morimoto, Setsuo, Ohmoto, Takechiyo, Shigemoto, Hirosada, Shimizu, Hiroshi, Sunada, Terutake   +5 more
core   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source